Cargando…

Efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV infected children and adolescents: a systematic review and meta-analysis

BACKGROUND: Abacavir is one of the recommended nucleoside reverse transcriptase inhibitors (NRTIs) for the treatment of HIV infections among children and adolescents. However, there are concerns that the antiviral efficacy of abacavir might be low when compared to other NRTIs especially among childr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adetokunboh, Olatunji O., Schoonees, Anel, Balogun, Tolulope A., Wiysonge, Charles S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623925/ https://www.ncbi.nlm.nih.gov/pubmed/26502899 http://dx.doi.org/10.1186/s12879-015-1183-6

Ejemplares similares

Antiviral efficacy and safety of abacavir-containing combination antiretroviral therapy as first-line treatment of HIV-infected children and adolescents: a systematic review protocol
por: Adetokunboh, Olatunji O, et al.
Publicado: (2014)

Shifting tasks from pharmacy to non-pharmacy personnel for providing antiretroviral therapy to people living with HIV: a systematic review and meta-analysis
por: Mbeye, Nyanyiwe Masingi, et al.
Publicado: (2017)

Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
por: Palacios, R, et al.
Publicado: (2010)

Non-uptake of childhood vaccination among the children of HIV-infected mothers in sub-Saharan Africa: A multilevel analysis
por: Adetokunboh, Olatunji O., et al.
Publicado: (2018)

Effect of maternal HIV status on vaccination coverage among sub-Saharan African children: A socio-ecological analysis
por: Adetokunboh, Olatunji O., et al.
Publicado: (2018)

Abacavir antiretroviral therapy and indices of subclinical vascular disease in persons with HIV
por: Martinez, Claudia A., et al.
Publicado: (2022)

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
por: Ho, Sharlene, et al.
Publicado: (2020)

Safety and Efficacy of Ziagen (Abacavir Sulfate) in HIV-Infected Korean Patients
por: Ann, Heawon, et al.
Publicado: (2017)

Cochrane corner: universal screening for SARS-CoV-2 infection
por: Ndwandwe, Duduzile, et al.
Publicado: (2020)

Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis
por: Jesson, Julie, et al.
Publicado: (2022)

Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA)
Publicado: (2008)

A multilevel analysis of the determinants of missed opportunities for vaccination among children attending primary healthcare facilities in Kano, Nigeria: Findings from the pre-implementation phase of a collaborative quality improvement programme
por: Adamu, Abdu A., et al.
Publicado: (2019)

876. Renal Function, Lipid Profile, and Cardiovascular Events After Switching to Abacavir Containing Regimen in Antiretroviral-Therapy-Experienced People Living with HIV in Northern Thailand
por: Phudphong, Pitchaporn, et al.
Publicado: (2021)

Molecular Recognition of the Antiretroviral Drug Abacavir: Towards the Development of a Novel Carbazole-Based Fluorosensor
por: Idzik, Krzysztof Ryszard, et al.
Publicado: (2011)

SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen
por: Campo, R., et al.
Publicado: (2013)

Efficacy and Safety of Abacavir/Lamivudine/Zidovudine Plus Tenofovir in HBV/HIV-1 Coinfected Adults: 48-Week Data
por: Rodriguez, Allan E, et al.
Publicado: (2010)

Classification Schemes of COVID-19 High Risk Areas and Resulting Policies: A Rapid Review
por: Uthman, Olalekan A., et al.
Publicado: (2022)

Abacavir/lamivudine combination in the treatment of HIV: a review
por: Sivasubramanian, Geetha, et al.
Publicado: (2010)

Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children
por: Bunupuradah, Torsak, et al.
Publicado: (2015)

Abacavir forms novel cross-linking abacavir protein adducts in patients
por: Meng, Xiaoli, et al.
Publicado: (2014)

Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings
por: Kiertiburanakul, Sasisopin, et al.
Publicado: (2017)

A retrospective case-cohort study comparing treatment outcomes in abacavir versus stavudine containing first line antiretroviral treatment regimens in children <3yrs old, at a paediatric programme based in Soweto, South Africa
por: Cassim, Haseena, et al.
Publicado: (2017)

Publication practices of sub-Saharan African Cochrane authors: a bibliometric study
por: Mbuagbaw, Lawrence, et al.
Publicado: (2021)

Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan†
por: Kurita, Tomoko, et al.
Publicado: (2014)

Early changes in inflammatory and pro-thrombotic biomarkers in patients initiating antiretroviral therapy with abacavir or tenofovir
por: Padilla, Authors: Sergio, et al.
Publicado: (2011)

Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States
por: Dorjee, Kunchok, et al.
Publicado: (2021)

The Impact of Rubella Vaccine Introduction on Rubella Infection and Congenital Rubella Syndrome: A Systematic Review of Mathematical Modelling Studies
por: Motaze, Nkengafac Villyen, et al.
Publicado: (2021)

Methods used and lessons learnt in conducting document reviews of medical and allied health curricula – a key step in curriculum evaluation
por: Rohwer, Anke, et al.
Publicado: (2014)

Evaluating evidence-based health care teaching and learning in the undergraduate human nutrition; occupational therapy; physiotherapy; and speech, language and hearing therapy programs at a sub-Saharan African academic institution
por: Schoonees, Anel, et al.
Publicado: (2017)

Male partner unknown HIV status as a risk factor for HIV incidence and clinical outcomes in prevention of mother-to-child transmission of HIV programmes in 21 WHO priority countries: a systematic review protocol
por: Mmotsa, Tshiamo Moshading, et al.
Publicado: (2022)

Renal Safety of a Tenofovir-Containing First Line Regimen: Experience from an Antiretroviral Cohort in Rural Lesotho
por: Bygrave, Helen, et al.
Publicado: (2011)

Effect of female sex work-targeted community-based interventions along the HIV treatment cascade in sub-Saharan Africa: a systematic review protocol
por: Atuhaire, Lydia, et al.
Publicado: (2020)

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa
por: Ciaffi, Laura, et al.
Publicado: (2015)

Effect of community-based interventions targeting female sex workers along the HIV care cascade in sub-Saharan Africa: a systematic review and meta-analysis
por: Atuhaire, Lydia, et al.
Publicado: (2021)

Markers of inflammation and coagulation indicate a prothrombotic state in HIV-infected patients with long-term use of antiretroviral therapy with or without abacavir
por: Jong, Eefje, et al.
Publicado: (2010)

Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load
por: Galizzi, Nadia, et al.
Publicado: (2018)

Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
por: Swindells, Susan, et al.
Publicado: (2005)

Effects of a switch from tenofovir- to abacavir-based antiretroviral therapy, with or without atazanavir, on renal function
por: Guillemi, Silvia A, et al.
Publicado: (2016)

Access to HIV healthcare services by farm workers in sub-Saharan Africa (SSA): a systematic review protocol
por: Mlangeni, Nosimilo, et al.
Publicado: (2022)

Abacavir-induced liver toxicity
por: Pezzani, Maria Diletta, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u8kg6g9ahj9tmktug57vq2vu3v